Senior Director and Lead
EVIDERA
Meredith Smith, PhD, MPA, FISPE is Senior Director and Lead, Implementation Science Pillar in the Patient-Centered Research team at Evidera, PPD, a part of Thermo Fisher Scientific. Dr. Smith has over 20 years of experience in the biopharmaceutical/ biotechnology industry where she worked in health outcomes, drug safety and risk management, with a specific focus on the design, implementation and evaluation of risk minimization programs and Risk Evaluation and Mitigation Strategies (REMS) for a wide range of small and large molecule medicines as well as drug-device combination products in multiple therapeutic areas. Prior to industry, she was on the faculty at Memorial Sloan-Kettering Cancer Center, and subsequently the Mount Sinai School of Medicine, in New York City where she was a principal and co-principal investigator on numerous grant-funded research projects focusing on healthcare system interventions to improve quality of life, adjustment to illness, symptom management, and medication adherence among cancer patients and persons living with HIV/AIDS. Previously, Dr. Smith worked in public health, holding a variety of positions at the New York City Health Department and the US Centers for Disease Control and Prevention. Dr. Smith is trained as a health services researcher and behavioral scientist, and received her PhD from New York University’s Robert E. Wagner School of Public Service. Additionally, she is an adjunct professor in the International Center for Regulatory Science, School of Pharmacy at the University of Southern California, Los Angeles. She has published extensively in the health sciences literature and been a member of three CIOMS Working Groups, IMI-PREFER, and has been an invited speaker at Food and Drug Administration (FDA) public workshops and internal meetings. She is also a Fellow of the International Society of Pharmacoepidemiology.
Disclosure information not submitted.
Wednesday, May 10, 2023
08:30 – 16:00 CEST